[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Survey and Trend Research 2018

June 2018 | 90 pages | ID: G80D91ABAB3EN
99Strategy

US$ 2,600.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain
  • Raw Materials
  • Cost
  • Technology
  • Consumer Preference
Industry Overall:
  • History
  • Development & Trend
  • Market Competition
  • Trade Overview
  • Policy
Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):
  • Regional Market
  • Production Development
  • Sales
  • Regional Trade
  • Regional Forecast
Company (Amgen Inc, Amorepacific Corp, BCN Peptides SA, Centrexion Therapeutics Corp, DoNatur GmbH, DoNatur GmbH, Flex Pharma Inc, Grunenthal GmbH, Kyowa Hakko Kirin Co Ltd, Medifron DBT Co Ltd, Neurim Pharmaceuticals Ltd, Pila Pharma AB, Sylentis SAU, Toray Industries Inc, Vitality Biopharma Inc etc.):
  • Company Profile
  • Product & Service
  • Business Operation Data
  • Market Share
Investment Analysis:
  • Market Features
  • Investment Opportunity
  • Investment Calculation
PART 1 INDUSTRY OVERVIEW

1.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 1 MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Amgen Inc (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Amorepacific Corp (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 BCN Peptides SA (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Centrexion Therapeutics Corp (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 DoNatur GmbH (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 DoNatur GmbH (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Flex Pharma Inc (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Grunenthal GmbH (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Kyowa Hakko Kirin Co Ltd (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Medifron DBT Co Ltd (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Neurim Pharmaceuticals Ltd (Company Overview, Sales Data etc.)
4.12 Pila Pharma AB (Company Overview, Sales Data etc.)
4.13 Sylentis SAU (Company Overview, Sales Data etc.)
4.14 Toray Industries Inc (Company Overview, Sales Data etc.)
4.15 Vitality Biopharma Inc (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

LIST OF TABLES

TABLE GLOBAL TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 1 MARKET 2012-2017, BY TYPE, IN USD MILLION

Table Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market 2012-2017, by Type, in Volume
Table Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast 2018-2023, by Type, in USD Million
Table Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast 2018-2023, by Type, in Volume
Table Amgen Inc Overview List
Table Transient Receptor Potential Cation Channel Subfamily V Member 1 Business Operation of Amgen Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amorepacific Corp Overview List
Table Transient Receptor Potential Cation Channel Subfamily V Member 1 Business Operation of Amorepacific Corp (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BCN Peptides SA Overview List
Table Transient Receptor Potential Cation Channel Subfamily V Member 1 Business Operation of BCN Peptides SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Centrexion Therapeutics Corp Overview List
Table Transient Receptor Potential Cation Channel Subfamily V Member 1 Business Operation of Centrexion Therapeutics Corp (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table DoNatur GmbH Overview List
Table Transient Receptor Potential Cation Channel Subfamily V Member 1 Business Operation of DoNatur GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table DoNatur GmbH Overview List
Table Transient Receptor Potential Cation Channel Subfamily V Member 1 Business Operation of DoNatur GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Flex Pharma Inc Overview List
Table Transient Receptor Potential Cation Channel Subfamily V Member 1 Business Operation of Flex Pharma Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Grunenthal GmbH Overview List
Table Transient Receptor Potential Cation Channel Subfamily V Member 1 Business Operation of Grunenthal GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kyowa Hakko Kirin Co Ltd Overview List
Table Transient Receptor Potential Cation Channel Subfamily V Member 1 Business Operation of Kyowa Hakko Kirin Co Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Medifron DBT Co Ltd Overview List
Table Transient Receptor Potential Cation Channel Subfamily V Member 1 Business Operation of Medifron DBT Co Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Neurim Pharmaceuticals Ltd Overview List
Table Transient Receptor Potential Cation Channel Subfamily V Member 1 Business Operation of Neurim Pharmaceuticals Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pila Pharma AB Overview List
Table Transient Receptor Potential Cation Channel Subfamily V Member 1 Business Operation of Pila Pharma AB (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sylentis SAU Overview List
Table Transient Receptor Potential Cation Channel Subfamily V Member 1 Business Operation of Sylentis SAU (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Toray Industries Inc Overview List
Table Transient Receptor Potential Cation Channel Subfamily V Member 1 Business Operation of Toray Industries Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Vitality Biopharma Inc Overview List
Table Transient Receptor Potential Cation Channel Subfamily V Member 1 Business Operation of Vitality Biopharma Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Revenue Share, by Companies, in USD Million
Table Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Volume 2012-2017, by Companies, in Volume
Table Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Revenue Share, by Companies in 2017, in Volume
Table Transient Receptor Potential Cation Channel Subfamily V Member 1 Demand 2012-2017, by Application, in USD Million
Table Transient Receptor Potential Cation Channel Subfamily V Member 1 Demand 2012-2017, by Application, in Volume
Table Transient Receptor Potential Cation Channel Subfamily V Member 1 Demand Forecast 2018-2023, by Application, in USD Million
Table Transient Receptor Potential Cation Channel Subfamily V Member 1 Demand Forecast 2018-2023, by Application, in Volume
Table Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market 2012-2017, by Region, in USD Million
Table Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market 2012-2017, by Region, in Volume
Table Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast 2018-2023, by Region, in USD Million
Table Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast 2018-2023, by Region, in Volume

LIST OF FIGURES

Figure Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Chain Structure
Figure Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Growth 2012-2017, by Type, in USD Million
Figure Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Growth 2012-2017, by Type, in Volume
Figure Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region


More Publications